Start Learning Free

Before You Begin

Question #46737

Difficulty: 8/10 | 🟢 Free

The Question

In the pathogenesis of HIV, infected macrophages survive and act as an 'HIV factory' by continuously producing viral progeny. A researcher develops a novel drug that specifically inhibits the host cell's membrane-scission machinery (the ESCRT pathway), which is normally responsible for forming multivesicular bodies in the endomembrane system. Which of the following events in the HIV life cycle will be directly halted by this drug?

Options

  • A.

    Reverse transcription of viral RNA into double-stranded cDNA in the host cytoplasm.

  • B.

    Integration of the viral genome into the host macrophage DNA to form a provirus.

  • C.

    Synthesis of viral RNA and polyproteins by the host's transcriptional and translational machinery.

  • D.

    Acquisition of the viral lipid envelope and the release of mature progeny virions.

Check Your Answer

Correct Answer

Step-by-Step Solution

Explanation

How the Examiner Thinks

Evolutionary_Exception

Tackle problems where standard rules evolve or change based on specific environmental constraints.

Concepts Behind This Question

HIV_Replication|Plasma_Membrane|Endomembrane_System

Why This Question Is Tricky

Common Mistakes

Conceptual Pivot: Students often memorize the roles of specific viral enzymes (Reverse Transcriptase, Integrase, Protease) but overlook the mechanical cell biology behind how the virus physically exits the cell.

The trap relies on the misconception that viral budding is a passive or purely viral-driven event, rather than an active hijacking of the host's own endomembrane/vesicular trafficking system.

By linking Class 12 'Human Health and Disease' (HIV factory) with Class 11 'Cell Biology' (Endomembrane system), it tests true NCERT-Plus synthesis.

Quick Facts About This Question

Question Information

SubjectBiology
ChapterCell – The Unit of Life - Class 11
ConceptEndomembrane System Connectivity
Difficulty8
Cognitive Load5
Target Solve Time120 sec
AccessFree